Obstructive sleep apnea and cardiovascular risk
- PMID: 18516275
- PMCID: PMC2387304
Obstructive sleep apnea and cardiovascular risk
Abstract
Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and pulmonary hypertension.
Keywords: C-Reactive protein (CRP); Cheynes Stokes respiration-central sleep apnea (CSR-CSA); apnea-hypopnea index (AHI); obstructive sleep apnea (OSA); polysomnography, overlap syndrome; sleep disordered breathing (SDB).
References
-
- Atwood CW, Jr, McCrory D, Garcia JGN, et al. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:72–7. - PubMed
-
- Bokinsky G, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest. 1995;108:625–30. - PubMed
-
- Block AJ, Boysen PG, Wynne JW, et al. Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance. New Engl J Med. 1979;300:513–7. - PubMed
-
- Bradley TD, Floras JS. Sleep apnea and heart failure – Part I: obstructive sleep apnea. Circulation. 2003;107:1671. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
